ID   IIB-BR-G-MT
AC   CVCL_T742
SY   Instituto de Investigaciones Bioquimicas-BReast cancer-G MeTastatic
DR   Cosmic; 1507367
DR   Wikidata; Q54897421
RX   PubMed=9620446;
RX   PubMed=21308409;
CC   Population: Caucasian.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B410 ! IIB-BR-G
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
RX   PubMed=9620446;
RA   Bover L.C., Barrio M.M., Bravo A.I., Slavutsky I., Larripa I., Bolondi A.,
RA   Ayala M., Mordoh J.;
RT   "The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos
RT   oncogenes in vitro and is spontaneously metastatic in vivo.";
RL   Cell. Mol. Biol. 44:493-504(1998).
//
RX   PubMed=21308409; DOI=10.1007/s10549-011-1360-2;
RA   Roberti M.P., Barrio M.M., Bravo A.I., Rocca Y.S., Arriaga J.M.,
RA   Bianchini M., Mordoh J., Levy E.M.;
RT   "IL-15 and IL-2 increase cetuximab-mediated cellular cytotoxicity
RT   against triple negative breast cancer cell lines expressing EGFR.";
RL   Breast Cancer Res. Treat. 130:465-475(2011).
//